Johnson Investment Counsel’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-19,107
| Closed | -$3.52M | – | 602 |
|
|
2020
Q1 | $3.52M | Buy |
19,107
+9,406
| +97% | +$1.77M | 0.08% | 127 |
|
|
2019
Q4 | $1.85M | Sell |
9,701
-766
| -7% | -$138K | 0.03% | 207 |
|
|
2019
Q3 | $1.76M | Buy |
10,467
+7,381
| +239% | +$1.2M | 0.04% | 203 |
|
|
2019
Q2 | $516K | Sell |
3,086
-674
| -18% | -$93.3K | 0.01% | 417 |
|
|
2019
Q1 | $550K | Sell |
3,760
-153
| -4% | -$22.2K | 0.01% | 397 |
|
|
2018
Q4 | $523K | Sell |
3,913
-1,803
| -32% | -$296K | 0.01% | 395 |
|
|
2018
Q3 | $1.09M | Buy |
5,716
+142
| +3% | +$26.1K | 0.02% | 310 |
|
|
2018
Q2 | $929K | Sell |
5,574
-582
| -9% | -$93.4K | 0.02% | 319 |
|
|
2018
Q1 | $1.03M | Sell |
6,156
-5,335
| -46% | -$895K | 0.03% | 273 |
|
|
2017
Q4 | $1.88M | Sell |
11,491
-4,421
| -28% | -$793K | 0.05% | 188 |
|
|
2017
Q3 | $3.26M | Buy |
15,912
+447
| +3% | +$104K | 0.09% | 145 |
|
|
2017
Q2 | $3.76M | Sell |
15,465
-487
| -3% | -$114K | 0.1% | 125 |
|
|
2017
Q1 | $3.81M | Buy |
15,952
+687
| +5% | +$160K | 0.11% | 126 |
|
|
2016
Q4 | $3.21M | Sell |
15,265
-6,072
| -28% | -$1.26M | 0.1% | 136 |
|
|
2016
Q3 | $4.91M | Sell |
21,337
-388
| -2% | -$94.8K | 0.16% | 104 |
|
|
2016
Q2 | $5.02M | Buy |
21,725
+642
| +3% | +$148K | 0.17% | 104 |
|
|
2016
Q1 | $5.65M | Buy |
21,083
+231
| +1% | +$66.1K | 0.2% | 90 |
|
|
2015
Q4 | $6.52M | Buy |
20,852
+228
| +1% | +$67.9K | 0.23% | 85 |
|
|
2015
Q3 | $5.61M | Buy |
+20,624
| New | +$6.34M | 0.21% | 89 |
|
|
2015
Q2 | – | Sell |
-17,507
| Closed | -$5.21M | – | 560 |
|
|
2015
Q1 | $5.21M | Sell |
17,507
-242
| -1% | -$69K | 0.17% | 98 |
|
|
2014
Q4 | $4.57M | Buy |
17,749
+689
| +4% | +$172K | 0.15% | 105 |
|
|
2014
Q3 | $4.12M | Buy |
+17,060
| New | +$3.82M | 0.14% | 107 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Johnson Investment Counsel's AGN Position: Q2 2020 in Review
Johnson Investment Counsel sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 19,107 shares — an estimated $3.52M sold.
Johnson Investment Counsel first reported a position in AGN in Q3 2014 and held it in 22 quarters. The position peaked at $6.52M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Johnson Investment Counsel reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Johnson Investment Counsel sold 19,107 Allergan plc shares in Q2 2020, an estimated $3.52M.
- Johnson Investment Counsel first reported a position in Allergan plc in Q3 2014 and held it in 22 quarters.
- Johnson Investment Counsel's Allergan plc position peaked at $6.52M in Q4 2015.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Johnson Investment Counsel's 13F filing for Q2 2020, filed 13 Aug 2020.